Gilead’s Covid-19 Drug is Mediocre. It Will Be a Blockbuster Anyway. by BY KATIE THOMAS

This entry was posted in Health Weight Watchers and tagged Health NYT on by

Gilead Sciences said Wednesday that remdesivir, which has been authorized for emergency use since the spring, brought in $873 million in revenues so far this year.

Published: October 29, 2020 at 03:06PM

from NYT Health https://ift.tt/34BnUum